Phlo Secures £9m Investment for Business Expansion
Phlo, a Glasgow-based digital pharmacy company, has recently closed a £9m growth investment round to support its plans for expansion. The funding will enable Phlo to extend its reach and enhance its service offerings, positioning it as a key player in the UK digital healthcare industry.
This investment comes on the heels of a successful £10m Series A raise and the acquisition of TruePill UK assets. The funding round was led by Par Equity, with participation from Thairm Bio and Scottish Enterprise. Phlo is now poised to grow its presence within the UK, providing more patients with access to its array of digital healthcare services.
The company’s offerings include Phlo Digital Pharmacy, a medication management service for both NHS and private patients; Phlo Connect, an API-driven digital platform for healthcare providers; and Phlo Clinic, an on-demand treatment service. With plans to enhance partnerships and technology services, Phlo is committed to becoming a comprehensive digital healthcare provider in the UK.
Paul Munn, managing partner at Par Equity, expressed excitement about supporting Phlo’s growth trajectory in the digital healthcare space. Nadeem Sarwar, Phlo’s founder and CEO, highlighted the significance of the investment round, emphasizing the opportunities it will unlock for the company’s expansion.
